Tag: combo
Merck scraps Keytruda lung cancer trial adding Bristol Myers’ Yervoy. What...
Merck’s Keytruda is without doubt the king in previously untreated non-small cell lung cancer, but the company wanted to see whether adding another immuno-oncology agent...
ESMO: Merck’s Keytruda-chemo combo shows survival ‘trend,’ but can’t top chemo...
Merck’s Keynote-361 study in newly diagnosed metastatic bladder cancer asked a key question: Could adding Keytruda to chemo improve on chemo, the standard of...
Merck, Eisai’s Keytruda-Lenvima combo stonewalled in liver cancer after Roche’s first-in-class...
Tumor response data previously won Merck & Co. and partner Eisai an FDA breakthrough therapy designation for the combination of PD-1 star Keytruda and...
